News | Stroke | February 16, 2023

Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive Stroke

Acute ischemic stroke patients with each PIRI score on 5-point scale

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), percent insular ribbon infarction (PIRI) complements current stroke outcome predictors, classifying patients with slowly progressive stroke who could benefit from late-window endovascular thrombectomy (EVT).

Noting that PIRI was independently associated with infarct growth rate and 90-day outcome, “PIRI may help identify patients who could benefit from late-window EVT when requiring transfer to EVT-capable centers,” wrote head researcher Robert W. Regenhardt, MD, PhD, from the department of neurology at Massachusetts General Hospital and Harvard Medical School.

Analyzing a previous clinical trial of acute stroke patients untreated with reperfusion therapies from January 2007 to June 2009, Regenhardt et al. reevaluated 31 trial patients (median age, 71 years; 12 female, 19 male) with anterior-circulation large-vessel occlusion who underwent serial MRI examinations. Two neuroradiologists independently scored PIRI on presentation MRI—mild (0-1), moderate (2), severe (3-4)—based upon length ratios of the insula portion showing restricted diffusion to the insula’s total length. A 90-day modified Rankin Scale (mRS) was also obtained.

Ultimately, in multivariable models controlling for age, large-vessel occlusion location, and collateral pattern, PIRI category was a significant independent predictor of presentation-to-48-hour infarct growth rate (β=1.3) and 90-day mRS ≤2 (OR=0.2). Sensitivity and specificity for predicting 90-day mRS ≤2 were 90% and 84% for mild-to-moderate PIRI, versus 70% and 74% for symmetric collateral pattern.

“To our knowledge,” the authors of this AJR accepted manuscript added, “the present study is the first to show the PIRI category to be an independent predictor of 90-day mRS <2 in multivariable models.”

For more information: www.arrs.org


Related Content

News | Stroke

March 15, 2023 — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence ...

Home March 15, 2023
Home
News | Stroke

February 21, 2023 — Strokes are a leading cause of morbidity and mortality in the United States, as well as around the ...

Home February 21, 2023
Home
News | Stroke

February 20, 2023 — A novel Stroke Preclinical Assessment Network (SPAN) identified potential neuroprotective effects ...

Home February 20, 2023
Home
News | Stroke

February 15, 2023 — Thrombolysis use increased from 4% in 2010 to 14% in 2020 in the traditionally underserved urban ...

Home February 15, 2023
Home
News | Stroke

February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 14, 2023
Home
News | Stroke

February 14, 2023 — A large international clinical study finds that patients with large strokes had a dramatically ...

Home February 14, 2023
Home
News | Stroke

February 14, 2023 — Using blood pressure medications to lower systolic blood pressure immediately after mechanical clot ...

Home February 14, 2023
Home
News | Stroke

February 10, 2023 — A study of two widely used cardiovascular medications — cilostazol and isosorbide mononitrate — in ...

Home February 10, 2023
Home
News | Stroke

February 10, 2023 — The neuroprotectant ApTOLL, a medication that may shield the brain from tissue damage, was linked to ...

Home February 10, 2023
Home
News | Stroke

February 10, 2023 — Irregular heart rhythms were detected in about 1 in 5 people who survived an ischemic stroke due to ...

Home February 10, 2023
Home
Subscribe Now